Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.38% | 23.83% | 25.79% | 19.80% | 5.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.38% | 23.83% | 25.79% | 19.80% | 5.18% |
| Cost of Revenue | 13.43% | 30.95% | 54.80% | 49.03% | 28.24% |
| Gross Profit | 23.84% | 21.81% | 18.51% | 12.67% | -0.37% |
| SG&A Expenses | 30.40% | 29.17% | 20.75% | 8.85% | 1.12% |
| Depreciation & Amortization | 10.82% | -3.26% | 9.14% | 6.85% | 3.50% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.07% | 28.15% | 25.34% | 14.18% | 2.89% |
| Operating Income | -47.99% | -43.85% | -23.86% | 2.64% | 4.73% |
| Income Before Tax | -14.91% | -39.76% | -30.40% | -4.00% | -23.57% |
| Income Tax Expenses | -1,105.92% | -1,105.92% | -961.46% | -826.86% | 69.75% |
| Earnings from Continuing Operations | -5.35% | -28.71% | -19.28% | 6.11% | -27.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.35% | -28.71% | -19.28% | 6.11% | -27.00% |
| EBIT | -47.99% | -43.85% | -23.86% | 2.64% | 4.73% |
| EBITDA | -55.68% | -56.22% | -26.59% | 4.90% | 5.79% |
| EPS Basic | -3.09% | -26.22% | -17.40% | 7.42% | -24.54% |
| Normalized Basic EPS | -60.60% | -72.96% | -40.77% | -10.26% | -3.78% |
| EPS Diluted | -0.29% | -21.78% | -13.29% | 13.56% | -12.02% |
| Normalized Diluted EPS | -57.77% | -69.03% | -35.19% | -8.33% | -1.72% |
| Average Basic Shares Outstanding | 2.52% | 2.57% | 2.14% | 1.58% | 1.71% |
| Average Diluted Shares Outstanding | 5.54% | 5.38% | 6.98% | 3.75% | 3.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
